: Neurofibromin protein size and mass predictions from SAXS and SANS analysis. Values are calculated from the data in Fig. 1D and Fig. S5 , including radius of gyration (Rg), maximum dimension (Dmax), predicted molecular mass (M) and predicted oligomeric state. Cell pellets were homogenized in the lysis buffers below prior to lysis. Lysis buffers also served as the base buffers for the IMAC purification steps. The final buffers were used as the running buffer during preparative size exclusion chromatography and for long-term storage of purified proteins. All lysis buffers also contained protease inhibitors (1:100 v/v, Sigma P-8849), and all final buffers contained protease inhibitors (1:1000 v/v, Sigma P-8849). Where two final buffers are noted, the first was used in the data shown in the manuscript, while the buffer in parentheses was used to confirm behavior of the protein in lower salt condition size exclusion chromatography. Figure S1: Sedimentation equilibrium of full-length neurofibromin. Sedimentation equilibrium absorbance data for a solution of neurofibromin at 550 nM collected at 3,000 (blue), 5,000 (red) and 7,000 (green) rpm analyzed in terms of a non-interacting single ideal solute. Solid lines show the global best-fit, with the corresponding residuals shown in the plot above. For clarity, every third experimental data point is displayed. 
Domain Amino Acids Lysis Buffer 1 Final Buffer 1

Full length
2-2818 A A (G) ABC 2-1540 B C (G) ABCD 2-1820 D D CDEF 861-2818 D E DEF 1541-2818 B C (G) EF 1821-2818 C C C*D 1085-1816 C C D 1541-1820 E F C* 1085-1530 D F GRD 1172-1530 E F GRD 1198-1530 E F GRD 1203-1530 E
S-5
S-14
Figure S11: Potential model for the proposed interaction of neurofibromin C and E domains. One possible model for how the subunits of neurofibromin are aligned in the dimer which is consistent with experimental observations and the size of the various domains.
